Recently, it was demonstrated that IL-33 improved Aβ pathology by reprogramming chromatin accessibility and PU.1 transcription factor binding in microglial cells in Alzheimer’s disease [217]. Here, IL33 is linked to early-onset autosomal dominant Alzheimer disease.